ArticleEuropean radiology2026
CT-derived body composition predicts futile upfront resection in pancreatic cancer: a multicenter study.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pretherapeutic radiological sarcopenia in pancreatic ductal adenocarcinoma: a narrative review.Future science OA · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
purposeTo evaluate the utility of CT-derived body composition in predicting futile pancreatectomy and to develop a risk-stratification model for patients with pancreatic ductal adenocarcinoma (PDAC). MATERIALS AND
methodsPatients with anatomically resectable PDAC who underwent upfront pancreatectomy between March 2015 and November 2024 at three institutions were retrospectively included. Futile pancreatectomy was defined as death or recurrence within 6 months postoperatively. Body composition metrics were derived from skeletal muscle and adipose tissue segmented at the third lumbar level on preoperative CT, including the skeletal muscle index (SMI), deviation from sex-specific sarcopenia thresholds, and visceral fat-related ratios. A futility risk model was developed and validated using multivariable logistic regression, and its prognostic association with overall survival (OS) was assessed using Cox regression.
resultsA total of 604 patients (median age, 67.0 years [interquartile range, 60.0-72.0]; 348 males) were included, comprising 354 in the derivation cohort and 250 in the validation cohort. Futile pancreatectomy occurred in 20.2% of patients. Carbohydrate antigen 19-9, tumor size on CT, and SMI category, defined by relative deviation from sex-specific sarcopenia thresholds, were independent predictors and constituted the proposed futility risk model. In the validation cohort, the model achieved an area under the receiver operating characteristic curve of 0.750 (95% confidence interval (CI): 0.665-0.834) and was independently associated with OS after resection (HR, 1.53; 95% CI, 1.33-1.77; p < 0.001) after adjustment for pathological predictors.
conclusionsThe proposed model incorporating SMI predicts futile upfront resection in PDAC with moderate discrimination and provides preoperative prognostic information for OS. KEY POINTS: Question Can CT-derived body composition improve preoperative identification of patients with resectable pancreatic ductal adenocarcinoma who are at high risk of futile upfront pancreatectomy? Findings A model integrating CT-derived skeletal muscle index category, tumor size, and CA 19-9 achieved good discrimination for futile pancreatectomy and independently predicted overall survival. Clinical relevance By incorporating CT-derived skeletal muscle index category as an important patient-related factor, the proposed model for futile resection improves predictive performance and may help inform treatment sequencing between upfront surgery and neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma.
Indexed as
Identifiers
42209831What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.